Volume 64, Issue 3, Pages (September 2013)

Slides:

Advertisements

Similar presentations

Volume 58, Issue 5, Pages (November 2010)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 70, Issue 6, Pages (December 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

European Urology Focus

Volume 63, Issue 2, Pages (February 2013)

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Volume 57, Issue 6, Pages (June 2010)

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Volume 69, Issue 1, Pages (January 2016)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 53, Issue 5, Pages (May 2008)

Nerve Distribution along the Prostatic Capsule

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Let the Games Begin (with EAU Approval)

Volume 73, Issue 5, Pages (May 2018)

Volume 72, Issue 5, Pages (November 2017)

Volume 58, Issue 1, Pages (July 2010)

John P. Mulhall, Francesco Montorsi European Urology

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 61, Issue 5, Pages (May 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 66, Issue 4, Pages (October 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 50, Issue 4, Pages (October 2006)

Volume 68, Issue 1, Pages (July 2015)

Volume 63, Issue 5, Pages (May 2013)

Volume 54, Issue 6, Pages (December 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 2, Pages (August 2009)

Volume 64, Issue 3, Pages (September 2013)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

The PSA Era is not Over for Prostate Cancer

Volume 59, Issue 3, Pages e7-e8 (March 2011)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 56, Issue 1, Pages (July 2009)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 68, Issue 6, Pages e134-e135 (December 2015)

Volume 64, Issue 6, Pages (December 2013)

Volume 70, Issue 3, Pages e72-e74 (September 2016)

Volume 70, Issue 6, Pages (December 2016)

Volume 60, Issue 1, Pages (July 2011)

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Volume 62, Issue 3, Pages (September 2012)

TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential Liang Cheng, Rodolfo Montironi,

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

2005 Update on Pathology of Prostate Biopsies with Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 2, Pages (February 2013)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Volume 53, Issue 6, Pages (June 2008)

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Joaquim Bellmunt European Urology Supplements

Volume 52, Issue 3, Pages (September 2007)

Volume 54, Issue 1, Pages (July 2008)

2005 Update on Pathology of Prostate Biopsies with Cancer

Presentation transcript:

Volume 64, Issue 3, Pages 519-521 (September 2013) Precise Morphologic Documentation with Large-format Histology of Clinical Findings in a Bladder Cancer Patient Andrea B. Galosi, Liang Cheng, Antonio Lopez-Beltran, Francesco Montorsi, Marina Scarpelli, Roberta Mazzucchelli, Rodolfo Montironi European Urology Volume 64, Issue 3, Pages 519-521 (September 2013) DOI: 10.1016/j.eururo.2013.06.001 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 (A) Baseline computed tomography (CT) scan shows solid bladder cancer (red arrow) causing left ureteral obstruction (U) and bladder diverticulum on the right side (black arrow); (B) CT scan shows shrunken tumor after chemotherapy (red arrow) with ureteral jet from left ureter (U) and diverticulum (black arrow); (C) whole-mount section of the bladder shows the diverticulum; (D) whole-mount section of the bladder with tumor (arrow) adjacent to the intramural part of the ureter (insert: urothelial carcinoma with regressive changes due to neoadjuvant chemotherapy). European Urology 2013 64, 519-521DOI: (10.1016/j.eururo.2013.06.001) Copyright © 2013 European Association of Urology Terms and Conditions